Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Lactoferrin wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
200–300 mg daily for adults; 100–200 mg/day for children
30–60 minutes before breakfast, Between meals on an empty stomach
Bovine lactoferrin capsule or powder (≥95% purity)
Indication-specific and clinician-directed. Ovulation induction: 2.5-7.5 mg once daily for 5 days early in the cycle (typically days 3-7). Breast cancer: 2.5 mg once daily continuously. Off-label male use mirrors 2.5 mg once to a few times weekly (NOT daily) titrated to testosterone/estradiol — a prescription drug, not an approved supplement regimen.
any
Oral letrozole 2.5 mg tablet (Femara / generic)
4–8 weeks of use
4–8 weeks
4–8 weeks
6–12 weeks
Per cycle (days 3-7 dosing)
Weeks to months
Months to years
Months to years
Effect of Lactoferrin Supplementation on Inflammation, Immune Function, and Prevention of Respiratory Tract Infections in Humans: A Systematic Review and Meta-analysis.
Advances in Nutrition (2022) · Meta analysis
Lactoferrin significantly reduced IL-6 in adults (mean difference: -24.9 pg/mL; 95% CI: -41.64, -8.08 pg/mL)
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials.
Clinical Nutrition ESPEN (2021) · Meta analysis
Pooled analysis of RCTs showed significant reduction in respiratory tract infection risk with lactoferrin supplementation
Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.
Nutrients (2022) · Meta analysis
Lactoferrin was non-inferior to ferrous sulfate for increasing hemoglobin and serum ferritin
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.
The New England journal of medicine (2014) · Rct · n=750
Double-blind multicenter RCT of 750 women with PCOS randomized to letrozole or clomiphene for up to five cycles, primary outcome live birth
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Cochrane Database of Systematic Reviews (2022) · Meta analysis
Cochrane systematic review of 41 RCTs (6522 women); letrozole was used in all trials
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Cochrane Database of Systematic Reviews (2018) · Meta analysis
Earlier Cochrane systematic review including 42 RCTs (7935 women); letrozole was used in all studies
Based on multiple meta-analyses showing OR 0.78 for RTI reduction. Effect more pronounced in children and preterm infants. Conservative estimates due to heterogeneity in populations studied.
AI-estimated from published studies. Interpret as directional guidance.
Lactoferrin has a higher evidence score (6.3/10 vs 5/10) and wins in 3 of 3 categories.
No known interactions between Lactoferrin and Letrozole have been documented in our database. However, always consult a healthcare provider before combining supplements.